PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 40 filers reported holding PRELUDE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $49,332 | -36.5% | 12,948 | -21.0% | 0.00% | – |
| Q1 2024 | $77,679 | -44.8% | 16,388 | -50.3% | 0.00% | – |
| Q4 2023 | $140,812 | -61.7% | 32,977 | -48.8% | 0.00% | – |
| Q1 2023 | $367,479 | +262.0% | 64,470 | +283.6% | 0.00% | – |
| Q4 2022 | $101,514 | -20.7% | 16,807 | +64.1% | 0.00% | – |
| Q4 2021 | $128,000 | -42.3% | 10,241 | +38.9% | 0.00% | – |
| Q3 2020 | $222,000 | – | 7,375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $66,362,000 | 1.23% |
| Baker Brothers Advisors | 10,123,824 | $66,918,000 | 0.44% |
| HHLR ADVISORS, LTD. | 583,333 | $3,856,000 | 0.10% |
| CAXTON ASSOCIATES LP | 85,992 | $568,000 | 0.08% |
| Virtus ETF Advisers LLC | 24,180 | $160,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 54,173 | $358,000 | 0.05% |
| DENALI ADVISORS LLC | 8,200 | $54,000 | 0.03% |
| PDT Partners, LLC | 12,641 | $84,000 | 0.01% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 2,402,595 | $15,881,153,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 36,949 | $244,000 | 0.01% |